Related Experiment Video
Updated: May 16, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
HIV medication therapy management services in community pharmacies
Yardlee Kauffman1, Vidya Nair, Keith Herist
1Underserved Care/Global Health Pharmacy Resident, University of Pittsburgh, PA, USA. yardlee.s.kauffman@kp.org
Journal of the American Pharmacists Association : Japha
|December 12, 2012
Summary
Community pharmacists can enhance human immunodeficiency virus (HIV) care through medication therapy management (MTM). This model improves adherence to antiretroviral therapy and patient retention in care, though challenges in training and support must be addressed.
Area of Science:
- Pharmacology
- Infectious Diseases
- Public Health
Background:
- Pharmacy services have historically supported HIV-infected individuals in inpatient and clinic settings.
- Community pharmacy settings offer a potential avenue for expanding HIV care services.
- Medication Therapy Management (MTM) is a recognized framework for optimizing patient outcomes.
Purpose of the Study:
- To propose a structure for pharmacist-delivered MTM services for HIV disease.
- To identify challenges in implementing and sustaining community-based HIV MTM programs.
- To advocate for the role of community pharmacists in HIV care.
Main Methods:
- Review of professional literature.
- Synthesis of existing MTM frameworks.
- Analysis of potential implementation barriers.
Main Results:
- Pharmacist-managed HIV MTM programs can improve adherence to antiretroviral therapy (ART).
- These programs can enhance patient retention in HIV care.
- Successful implementation requires addressing pharmacist training, education, and support.
Conclusions:
- Community pharmacists are well-positioned to provide MTM services for HIV patients.
- Pharmacist-led HIV MTM can be a vital model for improving patient outcomes.
- Overcoming implementation challenges is crucial for the success of these programs.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...